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3: (page 7, lines 178-184) The manuscript did not clearly describe the inclusion criteria of studies, although it described several exclusion criteria. To understand the result of this study, it is important to know well about what is the inclusion criteria in this study. Should the included studies discuss both the MV and VILI? How much should the included studies address MV? Should all the infants in the studies be on MV? 4: (page 11, lines 273 to page 12, lines 278) and (page 15, lines 356-359) and Figure 3 The author assessed the median time to public availability of results for studies completed before Sep 2007 and for those completed after Sep 2007 and implied that "More recent studies tended to be published earlier (Figure 3 )". However, it is not right to simply compare the median time from trial completion to public availability of results between studies completed in 1990-2007 and those in 2007-17 because recent studies (e.g. those completed in 2015-17) cannot be published more than 2 years after study completion unlike old studies as of 2017. The author should consider this bias due to the maximum time for each year. For the same reason, in the Figure  3 , the dots cannot be in the upper right part of the Figure. In fact, the Figure 2A showed that many studies completed in 2015 were unpublished as of Sep 2017 (database closure of this study) and probably many of these studies would be published after Sep 2017, which result in increasing the median time to public availability. To avoid misunderstanding of readers, it would be better to put a line for the maximum time to publication in each year of study completion in the Figure 3 (e.g. a line connecting the 12 months at Sep 2016, 24 months at Sep 2015 , 36 months at Sep 2014 . Considering the effect of this line, the author should discuss whether recent studies published earlier than old studies.
5: (page 12, lines 282) The authors described "40 clnincal trials (37%)" and "32 clinical trials (29%)" here. However, I believe these 40 studies and 32 studies included not only randomized controlled trials (RCT) but also observational studies (e.g. cohort studies) registered in the clnicaltrial.gov. If so, the authors should not use the words of "clinical trials" or "trials" here, rather they should use the words of "clinical studies" or "studies". Generally, the word of the "trials" should be used for studies assessing interventions on participants (typically randomized controlled trials). This misuse of the words of "clinical trials" or "trials" for studies that included observational studies were found in many places in the manuscript and need to be corrected.
Minor comments 1: (page 6, lines140-141) The author mentioned that "selective reporting of clinical trial results as well as unequal age representation in already published studies might introduce publication bias". Although I agree that "the selective reporting of clinical trial results" causes publication bias, "the unequal age representation" introduce is not publication bias, rather it is selection bias. I believe that the unequal age representation of pediatric MV studies is not due to un-publication of completed trials for child > 1 year, rather it is due to less trials conducted for child > 1 year than for infants < 1 year.
2: (page 8, lines 193-198) The author categorized the included studies into 5 research topic subgroups. It was a bit difficult for me to understand the subgroup of (i) biophysical/mechanical aspects of ventilation and of (iii) diagnostic issues. If possible, it would be helpful if the authors can explain more detail about each subgroup, or show some examples for them, or put a list of included studies and assigned subgroup topics in the supplement. Table 1) In the table 1, the denominators of the percentages of the number of published randomized studies (4th column in the table 1) was the overall number of studies (e.g. 41.3% in the first row = 45/109). However, it is better to set the denominators as the number of randomized studies (then, the first row should be 69.2% = 45/65). It is because the readers want to know how much percentages of the randomized studies were published. In addition, it is better to add a columns showing the enrollment in randomized studies and add percentages in the columns for the enrollment in published studies, enrollment in randomized studies, and enrollment in published randomized studies.
5: (page 12, lines 278)
The following sentence does not make sense. "Seven studies were started less than 12 months after the closure of our database (September 14, 2017) and six of them had been published already" Did the author mean that "Seven studies were completed less than 12 months before the closure of our database (September 14, 2017) and six of them had been published already"?
REVIEWER
Lincoln Smith University of Washington, School of Medicine United States of America REVIEW RETURNED 09-Jun-2018
GENERAL COMMENTS
In the manuscript "A cross-sectional study on publication status and age representation of clinical trials addressing mechanical ventilation and ventilator-induced lung injury in infants and children" the authors assessed the publication status of registered and completed clinical trials of MV and VILI in neonates and children from 0 -2017. The authors found that 32% of trials registered and completed on clinicaltrials.gov were unpublished, and that of those that were published, the median duration to publication was 22 months.
This is a descriptive study of the current state of literature on pediatric lung injury. The authors have identified an important problem in publication bias, and delayed reporting of results. This kind of study is important to help the field move forward. This kind of manuscript is a basis of rationale for future studies and to provide information to help solve a greater problem of reporting negative results in medical research.
Ventilator associated lung injury was a common term throughout 1990-2010. The authors might want to include this term in their search to assure that there aren't other studies that were missed.
Background and references should probably include review by Smith et al PCCM 2013, and two manuscripts by Schouten et al 2014 and 2015.
Inconsistent results reported in Abstract -Results -Authors state that 32% of trials were unpublished, but in the body of the manuscript they report that N = 32 studies (29%) were unpublished.
Needs editing for English grammar and typos throughout. 
REVIEWER

GENERAL COMMENTS
Thank you for the opportunity to review you work, "A cross-sectional study on publication status and age representation of clinical trials addressing mechanical ventilation and ventilator-induced lung injury in infants and children." This paper is designed to address the potential bias in the published literature based on the fact that not all studies are published, and those that are may only include a certain age group making them less representative of the entire pediatric field. I think that this is an important observation and deserves to be published.
General comments: There are grammatical errors throughout the manuscript, I would suggest that a native speaker review it.
Specific Comments:
1. Page 7, Line 188: How did you decide these age cutoffs? Age 14 seems arbitrary. Ultimately it may not be entirely relevant to your results given the majority of the studies are in younger children. However it would help to explain this decision.
2. Page 8, line 196. Please define what "drug application" and "diagnostic issues" mean in the methods section. You define this eventually but it would have made the methods easier to understand if you had defined these terms there.
3. Page 18, lines 450-455. I feel that you are giving mixed messages in this conclusion. You start the last paragraph by saying that this paper is designed to raise awareness about the fact that significant data remains unpublished. That makes sense and is consistent with the conclusion stated in the abstract.
However you then go on to say "We want to emphasize the need to publish all data derived from clinical studies on pediatric mechanical ventilation and VILI as soon as they are available in order to improve patient care, prevent further children from being exposed to repeated and potentially unnecessary research and diversify our understanding of artificial ventilation mechanics and pathophysiology in children." I am not sure that you can fairly make this conclusion. If data remains unpublished due to significant issues or errors with methodology, study design or data collection then it should remain unpublished. In order to make this conclusion you would need to have specific information about why studies remain unpublished.
VERSION 1 -AUTHOR RESPONSE
Reviewer 1 Reviewer Name: Tetsuya Isayama National Center for Child Health and Development, Tokyo, Japan
Major comments: 1. "(Page 7, line 170): The authors used the word "Bronchopulmonary dysplasia" as primary search term; however, they did not use the word "Chronic lung disease". Because the two words are used interchangeably for preterm infants, I think this study probably missed many studies discussing the lung injury of preterm infants. In fact, the search of the Clnicaltrial.gov using the primary term of "Bronchopulmonary dysplasia" with advanced selection parameters of "completed studies" and "child" provided 77 hits on May 26 in 2018 while the similar search using the primary term of "chronic lung disease" provided 171 hits." To 1. We thank the reviewer for his comment and agree with him, that the terms "bronchopulmonary dysplasia" and "chronic lung disease" can both refer to neonatal/preterm pulmonary diseases inflicted by an invasive mechanical ventilation procedure. Considering the reviewers' suggestion, we, too, performed another search at clinicaltrials.gov with the primary search term "chronic lung disease" and the advanced selection criteria "completed studies" and "child" on June 22, which now provided 173 hits. We analyzed these hits based on our selection criteria and found:
 166 out of these studies focused on chronic pulmonary diseases (mostly chronic obstructive pulmonary diseases) which were not clearly associated with/or induced by an invasive mechanical ventilation procedure. Such studies were omitted from our analysis according to our preset exclusion criteria.
 7 studies from this search were already been included in our manuscript.
We decided to focus on pulmonary damage in childhood following out of invasive mechanical ventilation primarily. Nevertheless, we agree with the reviewer, that chronic pulmonary childhood diseases such as obstructive airway diseases represent a considerable burden for the affected child and its development. Publication bias in that field might be present, however, we think, it should be assessed in a separate study.
In order to clarify our primary focus on pulmonary damage directly associated with/ or induced by invasive mechanical ventilation, we added additional information on inclusion criteria in the methods section, which now reads as follows:
Page 8, Para 2 "General inclusion criteria for studies were defined as: studies enrolling children on invasive mechanical ventilation, studies enrolling children with pulmonary disease which is clearly associated with mechanical damage by previous or ongoing invasive mechanical ventilation in terms of VILI." To 2. We thank the reviewer for addressing this important issue. We agree with him, that the degree of completeness of trial entry on clinicaltrials.gov is likely to depend on what annual time frame you look at. In our analysis, however, we did not restrict the time frame for trial start or completion regarding inclusion of studies into the analysis, because we 1) aimed for a high sample size and 2) intended to show a complete picture of the overall situation and changes over time.
To take into account the major regulatory milestones such as the establishment of clinicaltrials.gov, the ICMJE requirement of trial registration prior to publication, and the FDA Amendment Act of 2007 requiring publication of completed trials within 12 months, we highlighted the respective dates in Figure 3 . Thereby, the reader can get an impression on possible influences of these regulatory milestones on trial registration and publication patterns. We hope, the reviewer agrees to that.
We discussed that point in the limitations section of our manuscript. The new paragraph now reads as follows:
Page 21, Para 1: "Further, clinicaltrials.gov was made public in February 2000 and the ICMJE requirement to register all studies prior to publication was stated in September 2004. These dates might influence the study registration pattern and -more importantly -the respective publication status."
3. "(page 7, lines 178-184). The manuscript did not clearly describe the inclusion criteria of studies, although it described several exclusion criteria. To understand the result of this study, it is important to know well about what is the inclusion criteria in this study. Should the included studies discuss both the MV and VILI? How much should the included studies address MV? Should all the infants in the studies be on MV?" To 3. See our answer to "major comment 1" above. In fact, the Figure 2A showed that many studies completed in 2015 were unpublished as of Sep 2017 (database closure of this study) and probably many of these studies would be published after Sep 2017, which result in increasing the median time to public availability. To avoid misunderstanding of readers, it would be better to put a line for the maximum time to publication in each year of study completion in the Figure 3 (e.g. a line connecting the 12 months at Sep 2016, 24 months at Sep 2015 , 36 months at Sep 2014 . Considering the effect of this line, the author should discuss whether recent studies published earlier than old studies." To 4. We thank the reviewer for his thoughtful comment and his suggestions to clarify that there might be a bias regarding time to publication in the years 2015 to 2017 due to the closure of our database on September 2017. We considered and discussed this potential source of bias in our limitations section in the manuscript and we adjusted Figure 3 according to the reviewers' recommendation. The respective changes in the revised manuscript are as follows:
Page 21, Para 1 "In addition, publication status of studies registered as completed near September 2017 (closure of our database) must be interpreted carefully. Figure 3 shows that the maximum time to publication between 2015 to 2017 was about 2 years, which might implicate, that some studies, which had been completed in those years, might have been published after September 2017 and are thus included as "unpublished" in our analysis."
We connected the maximum time to publication with a line in Figure 3 B 5. "(page 12, lines 282). The authors described "40 clnincal trials (37%)" and "32 clinical trials (29%)" here. However, I believe these 40 studies and 32 studies included not only randomized controlled trials (RCT) but also observational studies (e.g. cohort studies) registered in the clnicaltrial.gov. If so, the authors should not use the words of "clinical trials" or "trials" here, rather they should use the words of "clinical studies" or "studies". Generally, the word of the "trials" should be used for studies assessing interventions on participants (typically randomized controlled trials). This misuse of the words of "clinical trials" or "trials" for studies that included observational studies were found in many places in the manuscript and need to be corrected." To 5. The reviewer is right in that point. The respective 40 and 32 studies also included some observational studies. According to his suggestion and to avoid misunderstandings, we desisted from the terms "clinical trials" and "trials" throughout the manuscript when applicable and wrote "clinical studies" and "studies" instead, as these terms include both RCTs and observational studies. We hope, the reviewer agrees to that. (see changes in the revised version of the manuscript with track changes)
Minor comments: 1. "(page 6, lines140-141). The author mentioned that "selective reporting of clinical trial results as well as unequal age representation in already published studies might introduce publication bias". Although I agree that "the selective reporting of clinical trial results" causes publication bias, "the unequal age representation" introduce is not publication bias, rather it is selection bias. I believe that the unequal age representation of pediatric MV studies is not due to un-publication of completed trials for child > 1 year, rather it is due to less trials conducted for child > 1 year than for infants < 1 year." To 1. We completely agree with the reviewer, that the unequal age representation is rather influenced by the fact, that less trials had been conducted in children > 1 year of age instead of selective reporting of trials. This fact is also covered by our data, which show, that considerably less studies have been performed in older children compared to children blow 1 year of age. Thus, our statement on page 6, lines 140-141, mentioned by the reviewer, is indeed not entirely correct. We now write the following and hope, the reviewer agrees to it:
Page 7 , Para 1 "However, besides the need for more clinical studies on pediatric MV and VILI, selective reporting of clinical study results might introduce publication bias and unequal age representation in already published studies might introduce an additional selection bias into the field."
Page 21, Para 2 "The study population was skewed towards children younger than one year which indicates that there might be an additional selection bias in the field and therefore a substantial need for clinical VILI research in older children."
Page 17, Para 1 "Our study revealed that publication bias in clinical pediatric invasive MV and VILI research may be present and would arise from unpublished data. Furthermore, there was a skewed distribution of investigated pediatric age groups towards patients below 1 year of age. This consequently would have an impact on the distribution of research study subtopics and, thereby, might introduce an additional selection bias in the field. "
2. " (page 8, lines 193-198) . The author categorized the included studies into 5 research topic subgroups. It was a bit difficult for me to understand the subgroup of (i) biophysical/mechanical aspects of ventilation and of (iii) diagnostic issues. If possible, it would be helpful if the authors can explain more detail about each subgroup, or show some examples for them, or put a list of included studies and assigned subgroup topics in the supplement." To 2. In order to provide more information about the principal focus of each research topic subgroup, we made the following additions to the supplements:
"Examples for assignment to research topic subgroup 3. "(page 10, line 248). The "see Figure 1 " here should be "see Figure 2 . Then, the author should indicate the Figure 1 somewhere else in the main text." To 3. We made the suggested corrections (see revised manuscript with track changes). Furthermore, we indicated Figure 1 in the following paragraph:
Page 10, Para 2 "If study results were published on PubMed, we did not further search for them in Google Scholar (see Figure 1) ."
Page 12, Para 1 "We identified N=109 registered and completed studies addressing pediatric invasive MV and VILI on clinicaltrials.gov with a total enrollment of 22233 study participants (see Figure 1 , Table 1 )."
4. "(page 11, Table 1 ). In the table 1, the denominators of the percentages of the number of published randomized studies (4th column in the table 1) was the overall number of studies (e.g. 41.3% in the first row = 45/109). However, it is better to set the denominators as the number of randomized studies (then, the first row should be 69.2% = 45/65). It is because the readers want to know how much percentages of the randomized studies were published. In addition, it is better to add a columns showing the enrollment in randomized studies and add percentages in the columns for the enrollment in published studies, enrollment in randomized studies, and enrollment in published randomized studies." To 4. We thank the reviewer for his thoughtful comment and made the required changes and additions to table 1 as suggested. The table now is formatted in horizontal format and thus excluded from the main text of the revised manuscript and uploaded as an additional word document instead.
5. "(page 12, lines 278). The following sentence does not make sense. "Seven studies were started less than 12 months after the closure of our database (September 14, 2017) and six of them had been published already" Did the author mean that "Seven studies were completed less than 12 months before the closure of our database (September 14, 2017) and six of them had been published already"?" To 5. We thank the reviewer for this important comment and corrected this statement.
Reviewer 2 Reviewer Name: Lincoln Smith University of Washington, School of Medicine, United States of America
We thank the reviewer for appreciating the results of our study.
Reviewer comments: 1. "Ventilator associated lung injury was a common term throughout 1990-2010. The authors might want to include this term in their search to assure that there aren't other studies that were missed." To 1. We thank the reviewer for his thoughtful comment and agree with him in that point. Accordingly, we performed an additional search at clinicaltrials.gov on June 22 using the primary search term "ventilator associated lung injury" and the advanced search terms "child" and "completed studies". This search revealed 19 search results:  1 out of these (NCT00935896) was already included in our analysis.
 17 out of these represented studies with a primary focus on ventilator associated pneumonias or infections. These, we did not include into our analysis, as such studies were excluded from our analysis according to our exclusion criteria.
 1 out of these (NCT03163108) with the title "Closed-loop Automatic Oxygen Control (CLAC-4) in Preterm Infants" was started in March 15, 2017 and would have met our inclusion criteria. Yet, the study was completed in January 12, 2018 which was after the close of our database (September 14, 2017, see Methods Section). Thus, we did not include this study into the manuscript and hope, the reviewer agrees with that.
We included the information of this additional search into Figure 1 and the Methods section of the revised version of our manuscript. "Current pre-clinical literature suggests age-dependent differences in pulmonary sensitivity and reaction to harmful mechanical ventilation [5] . Results from animal studies indicate an inverse correlation between age and VILI-susceptibility [10] [11] [12] . An age-dependent VILI susceptibility might also be assumable for humans but this still remains to be further investigated by translational research [13] . A careless transfer of VILI knowledge derived from studies in adult patients to mechanically ventilated children must be seen critical [14] . "
3. "Inconsistent results reported in Abstract -Results -Authors state that 32% of trials were unpublished, but in the body of the manuscript they report that N = 32 studies (29%) were unpublished." To 3. We are sorry for this mistake. It had been 32 unpublished studies (29%). We changed that in the abstract. (see revised version of the manuscript with track changes)
4. "Needs editing for English grammar and typos throughout." To 4. We addressed this issue and handed the manuscript to a native speaker for grammar -and typos proof-reading. You find the corrections marked in the revised version of the manuscript. We thank the reviewer for his appreciation of our work.
General comments: "There are grammatical errors throughout " We are sorry for this inconvenience. We addressed this issue and handed the manuscript to a native speaker for grammar -and typos proof-reading. You find the corrections marked in the revised version of the manuscript. (See our answer to comment 4 from reviewer 2).
Specific comments:
1. "Page 7, Line 188: How did you decide these age cutoffs? Age 14 seems arbitrary. Ultimately it may not be entirely relevant to your results given the majority of the studies are in younger children.
However it would help to explain this decision." To 1. We thank the reviewer for his comment and added an explanation to the methods section. The respective section now reads as follows:
Page 9, Para 1 "Patient age was categorized into three subgroups after evaluating the age representation pattern in the studies included in our analysis: below 1 year, between 1 and 14 years, above 14 years. This categorization was chosen because many studies on neonates also included children up to 1 year of age. The cut-off at 14 years was set because some studies in our analysis enrolled adult patients in addition to children, but most of those studies did not include children below 14 years of age."
2. "Page 8, line 196. Please define what "drug application" and "diagnostic issues" mean in the methods section. You define this eventually but it would have made the methods easier to understand if you had defined these terms there." To 2. We agree with the reviewer. We added a respective explanation. The section now reads as follows:
Page 9, Para 1 "We assigned follow-up studies to the age group(s) within which the mechanical ventilation event took place. Studies on extubation failure were included and assigned to the subtopic "weaning". One study on ECMO was included (NCT01423864) as mechanical ventilation parameters were primary study outcome measures. Studies were assigned to "drug application" if drugs had been given during MV and primary or secondary readout parameters were for example effect on ventilation parameters or patient outcome. Studies were assigned to "diagnostic issues", when they focused on a method to measure the adequacy of ventilation intensity or the pulmonary reaction towards invasive mechanical ventilation, for example by detecting inflammatory markers or physical pulmonary parameters like compliance during MV."
3. "Page 18, lines 450-455. I feel that you are giving mixed messages in this conclusion. You start the last paragraph by saying that this paper is designed to raise awareness about the fact that significant data remains unpublished. That makes sense and is consistent with the conclusion stated in the abstract. However you then go on to say "We want to emphasize the need to publish all data derived from clinical studies on pediatric mechanical ventilation and VILI as soon as they are available in order to improve patient care, prevent further children from being exposed to repeated and potentially unnecessary research and diversify our understanding of artificial ventilation mechanics and pathophysiology in children." I am not sure that you can fairly make this conclusion. If data remains unpublished due to significant issues or errors with methodology, study design or data collection then it should remain unpublished. In order to make this conclusion you would need to have specific information about why studies remain unpublished."
To 3. We thank the reviewer for raising this important issue. We softened the language, amended the paragraph accordingly and added a pertinent citation. The new section now reads as follows:
Page 21, Para 2 "While insufficient trial quality will be accounted for in excellent systematic reviews [48] , timely availability of data derived from clinical studies on pediatric mechanical ventilation and VILI can improve methodology for future clinical studies by learning from previous projects including unsuccessful ones. In addition, transparency in clinical research has the potential to improve patient care, prevent further children from being exposed to repeated and potentially unnecessary research and diversify our understanding of artificial ventilation mechanics and pathophysiology in children." 2014, etc.) . Considering the effect of this line, the author should discuss whether recent studies published earlier than old studies."
Reply from the authors To 4. We thank the reviewer for his thoughtful comment and his suggestions to clarify that there might be a bias regarding time to publication in the years 2015 to 2017 due to the closure of our database on September 2017. We considered and discussed this potential source of bias in our limitations section in the manuscript and we adjusted Figure 3 according to the reviewers' recommendation. The respective changes in the revised manuscript are as follows: Page 21, Para 1 "In addition, publication status of studies registered as completed near September 2017 (closure of our database) must be interpreted carefully. Figure 3 shows that the maximum time to publication between 2015 to 2017 was about 2 years, which might implicate, that some studies, which had been completed in those years, might have been published after September 2017 and are thus included as "unpublished" in our analysis." We connected the maximum time to publication with a line in Figure  3 B
Additional comments to the reply from the authors >> Thank you for trying to incorporate my comment into the Figure  3 . However, what I suggested was not adding the Figure 3B . Sorry for the confusion. What I suggested was that it would be better to put a line into the original Figure 3 (not making another Figure 3B ) for indicating the area above the line cannot included any studies technically due to the database closure date of this study (Sep 2017) . I uploaded an example for such a revision of the Figure 3 (I put a triangle rather than a line for clarifying further what I intended). The example figure attached indicated that any studies cannot appear in the right upper corner highlighted by the triangle. For example, if a study was completed in Jan 2014 and was published 48 months after the completion (namely Jan 2018), this study was not included in this manuscript because the publication date was after the database closure date of this study (Sep 2017) . And then, based on this example figure 3, the author should discuss whether "More recent studies tended to be published earlier ( Figure  3 )" or not. I believe that it is not right to simply compare the median time from trial completion to public availability of results between studies completed in 1990-2007 and those in 2007-17 as the authors mentioned in lines 31-38 of page 14 of the revised manuscript. I am not sure whether the recent studies were published earlier than before based on the example figure 3.
My pevious minor comment #5: 5. "(page 12, lines 278). The following sentence does not make sense. "Seven studies were started less than 12 months after the closure of our database (September 14, 2017) and six of them had been published already" Did the author mean that "Seven studies were completed less than 12 months before the closure of our database (September 14, 2017) and six of them had been published already"?"
Reply from the authors 
GENERAL COMMENTS
Thank you for the chance to review your revised paper. You have addressed the concerns that I raised on the original version.
VERSION 2 -AUTHOR RESPONSE
Reviewer 1 Reviewer Name: Tetsuya Isayama National Center for Child Health and Development, Tokyo, Japan Previous major comment 4: "Thank you for trying to incorporate my comment into the Figure 3 . However, what I suggested was not adding the Figure 3B . Sorry for the confusion. What I suggested was that it would be better to put a line into the original Figure 3 (not making another Figure 3B ) for indicating the area above the line cannot included any studies technically due to the database closure date of this study (Sep 2017) . I uploaded an example for such a revision of the Figure 3 (I put a triangle rather than a line for clarifying further what I intended). The example figure attached indicated that any studies cannot appear in the right upper corner highlighted by the triangle. For example, if a study was completed in Jan 2014 and was published 48 months after the completion (namely Jan 2018), this study was not included in this manuscript because the publication date was after the database closure date of this study (Sep 2017) . And then, based on this example figure 3, the author should discuss whether "More recent studies tended to be published earlier (Figure 3 Furthermore, we adjusted the respective section in the discussion, which now reads as follows:
Line 440 to 443 "In our analysis, there seems to be a positive impact of the FDAAA on the timely availability of clinical study results in pediatric MV and VILI research, as indicated in Figure 3 by the accumulation of timeto-publication-dots near the 12 months threshold line in more recent studies."
We further discussed the effect of the line in Figure 3 in the limitations section, which now reads as follows:
Line 518 to 525 "Our data show, that time to public availability of study results tended to center around 12 months in more recent studies, which is indicated by the accumulation of dots at the 12 months-threshold line in Figure 3 . However, we cannot exclude, that some recent studies, which are currently unpublished, might probably get published in the future after the closure of our database and would then appear as dots above the diagonal line at the right end of the time axis in Figure 3 . This makes the interpretation of the median time to publication difficult."
Previous minor comment 5: "The author revised the sentence as "Seven studies had been started less than 12 months before the closure of our database (September 14th, 2017) and six of them have been published already". Can I confirm again what the author mean? Did the author indicate that 7 studies were started (not completed) within 12 months of the closure of the database (Sep 14, 2017) and most of them (6 out of 7) already published as of Sep 14, 2017? I felt it was unusually fast because, to do that, they should started enrolling patients, then completed the study, analyzed the data, wrote the paper, submitted to the journals, went through peer-review process, and published as an article all within 12 months. Is this correct? Or, could the author clarify the meaning of the sentence?" Answer:
We are sorry for the inconvenience. We still had a spelling-mistake: it must mean "completed" instead of "started". We did only assess "completed" studies in our analysis. We corrected the spelling mistake in the revised version of our manuscript.
VERSION 3 -REVIEW
REVIEWER
Tetsuya Isayama National Center for Child Health and Development, Tokyo, Japan REVIEW RETURNED 18-Sep-2018
GENERAL COMMENTS
The authors correctly addressed my previous comments.
